ASSET | DATE | % RETURN |
---|---|---|
NioCorp Developments Ltd Common Stock (NB) | 3/17/2023 - 4/1/2023 | 695% |
Aimfinity Investment Corp I Warrant (AIMAW) | 3/17/2023 - 4/1/2023 | 158.06% |
Naas Technology Inc ADR (NAAS) | 3/17/2023 - 4/1/2023 | 147.1% |
Klotho Neurosciences (KLTOW) | 3/17/2023 - 4/1/2023 | 145.33% |
Scynexis (SCYX) | 3/17/2023 - 4/1/2023 | 138.1% |
Apollomics Inc Class A Ordinary Shares (APLM) | 3/17/2023 - 4/1/2023 | 136.1% |
Maris-Tech Ltd Warrants (MTEKW) | 3/17/2023 - 4/1/2023 | 131.02% |
Sonim Technologies (SONM) | 3/17/2023 - 4/1/2023 | 129.55% |
Local Bounti (LOCL) | 3/17/2023 - 4/1/2023 | 127.71% |
CBL International Limited Ordinary Shares (BANL) | 3/17/2023 - 4/1/2023 | 125.65% |
Brainstorm Cell Therapeutics (BCLI) | 3/17/2023 - 4/1/2023 | 112.9% |
United Homes (UHG) | 3/17/2023 - 4/1/2023 | 109.26% |
Inozyme Pharma (INZY) | 3/17/2023 - 4/1/2023 | 105.38% |
Biomea Fusion (BMEA) | 3/17/2023 - 4/1/2023 | 100.97% |
Oscar Health (OSCR) | 3/17/2023 - 4/1/2023 | 91.23% |
Torrid (CURV) | 3/17/2023 - 4/1/2023 | 88.74% |
Airnet Technology (ANTE) | 3/17/2023 - 4/1/2023 | 88.51% |
Tiziana Life Sciences (TLSA) | 3/17/2023 - 4/1/2023 | 88.21% |
Professional Diversity Network (IPDN) | 3/17/2023 - 4/1/2023 | 85.77% |
Quince Therapeutics (QNCX) | 3/17/2023 - 4/1/2023 | 84.83% |
Palisade Bio (PALI) | 3/17/2023 - 4/1/2023 | 83.33% |
First Citizens BancShares (FCNCA) | 3/17/2023 - 4/1/2023 | 82.03% |
Amprius Technologies (AMPX) | 3/17/2023 - 4/1/2023 | 80.33% |
Tempest Therapeutics (TPST) | 3/17/2023 - 4/1/2023 | 78.46% |
Starbox Group Holdings Ltd Ordinary Shares (STBX) | 3/17/2023 - 4/1/2023 | 77% |